[1]
Faiza Ahmed, P. Poudel, and A. Khanal, “Zanidatamab in HER2-Positive Biliary Tract Cancer: A First Narrative Literature Review”, JMHRP, vol. 2, no. 2, pp. 1–4, Oct. 2025.